OBJECTIVES:To describe and compare temporal changes in prevalence and incidence of psychotropic use (antipsychotics, antidepressants and benzodiazepines and related drugs; BZDRs) in persons with newly diagnosed Alzheimer's disease (AD) between university hospital districts of Finland during 2005-2011. METHODS:The MEDALZ study includes all community-dwellers of Finland who received a clinically verified AD diagnosis in 2005-2011 (N = 70,718). Prevalent and incident use of psychotropics among those who had received AD diagnosis less than one year ago were compared in 2005-2011. RESULTS:Regional differences in psychotropic use between university hospital districts were more evident in 2005 than 2011 for prevalent use of any psychotropic, antip...
Background: The aim of this study was to explore trends in treatment with antipsychotic medication i...
AbstractBackground/PurposePsychotropics are administered to control behavioral and psychological sym...
Background: Young-onset dementia (YOD) is defined as dementia that develops before the age of 65 yea...
<div><p>Objectives</p><p>To describe and compare temporal changes in prevalence and incidence of psy...
AbstractPsychotropic drugs are used for treatment of behavioral and psychological symptoms of dement...
Psychotropic drugs are frequently used for the treatment of behavioural and psychological symptoms o...
Background: We aimed to assess whether there were any changes in the use of psychotropic drugs in No...
Objectives: To determine factors associated with the antipsychotic (AP) prescription for people with...
Background: Despite the numerous warnings of European and national drug agencies as well as clinical...
OBJECTIVES: To compare the differences in prevalence of antipsychotic and adjunctive pharmacotherapy...
International audienceIntroduction: We aim to understand how patients with Alzheimer's disease (AD) ...
In Norway, consumption of psychotropic drug is increasing concomitant with huge variations across th...
Objectives: The aim of this study was to describe the course of psychotropic drug use in people with...
Background: The aim of this study was to explore trends in treatment with antipsychotic medication i...
AbstractBackground/PurposePsychotropics are administered to control behavioral and psychological sym...
Background: Young-onset dementia (YOD) is defined as dementia that develops before the age of 65 yea...
<div><p>Objectives</p><p>To describe and compare temporal changes in prevalence and incidence of psy...
AbstractPsychotropic drugs are used for treatment of behavioral and psychological symptoms of dement...
Psychotropic drugs are frequently used for the treatment of behavioural and psychological symptoms o...
Background: We aimed to assess whether there were any changes in the use of psychotropic drugs in No...
Objectives: To determine factors associated with the antipsychotic (AP) prescription for people with...
Background: Despite the numerous warnings of European and national drug agencies as well as clinical...
OBJECTIVES: To compare the differences in prevalence of antipsychotic and adjunctive pharmacotherapy...
International audienceIntroduction: We aim to understand how patients with Alzheimer's disease (AD) ...
In Norway, consumption of psychotropic drug is increasing concomitant with huge variations across th...
Objectives: The aim of this study was to describe the course of psychotropic drug use in people with...
Background: The aim of this study was to explore trends in treatment with antipsychotic medication i...
AbstractBackground/PurposePsychotropics are administered to control behavioral and psychological sym...
Background: Young-onset dementia (YOD) is defined as dementia that develops before the age of 65 yea...